GlaxoSmithKline’s new $50 million venture capital fund will be based out of the One Broadway building in Cambridge’s Kendall Square, inside an office of SR One, the drug giant’s corporate VC arm, a GSK spokesperson said.
The 16-floor One Broadway building also houses the Cambridge Innovation Center startup offices across a number of its floors, as well as venture capital firms Charles River Ventures and Highland Capital Partners.
{iframe}http://www.bizjournals.com/boston/blog/startups/2013/08/glaxosmithkline-bioelectronics-vc-fund.html{/iframe}